Reyataz 150 Mg, 200 Mg And 300mg Hard Capsules
by Bristol-Myers Squibb Pharmaceutical Limited
Reyataz 150 Mg, 200 Mg And 300mg Hard Capsules is supplied by Bristol-Myers Squibb Pharmaceutical Limited under product code REYATAZ 100 mg, REYATAZ 150 mg, REYATAZ 200 mg, REYATAZ 300 mg. This page provides both the Safety Data Sheet (SDS) and the Chemical Risk Assessment (CRA) for this substance, under GHS/CLP regulations for UK workplace use under COSHH. The full SDS and CRA documents are available to download above.
This SDS was last revised on 3 January 2017. The matching CRA is updated in line with SDS revisions. Workplaces handling this substance should retain a current SDS and risk assessment for the duration of use.
- Language
- English
- Regulation
- GHS/CLP
- Revision Date
- 03 Jan 2017
- Signal Word
- —
- Product Code
- REYATAZ 100 mg, REYATAZ 150 mg, REYATAZ 200 mg, REYATAZ 300 mg
- CAS Number
- —
Switch between the Safety Data Sheet and the Chemical Risk Assessment for this substance.
Need the full hazard breakdown? Precautionary statements, first aid, physical properties and exposure controls are in the full SDS PDF.
Need to download the Chemical Risk Assessment? The full CRA PDF includes all hazard classifications, regulatory statements and recommended controls.